Main Article Content

The efficacy of a Bismuth-protein-complex compound in the treatment of gastric and duodenal ulcers


G. Weiss
W. J. Serfontein

Abstract

In a clinical trial involving a total of 86 patiellls, the efficacy of Bicitropeptide (BCP) in The treatment of gastric and duodenal ulcers was investigated. The gastric ulcer group was treated on a double-blind basis with gastroscopic control, while in the duodenal ulcer group radiological evidence and clinical assessment were used as criteria. In the gastric ulcer group 60% of the patients were completely healed, while in a further 33·3% of the patienrs, The ulcer crater was reduced by more ihan two-thirds of the original size. In the control group, the corresponding figures were 8·3% and 41.6%. In The duodenal ulcer group 88% of the ulcers were considered completely healed. The advantages of Bicitropeptide therapy are discussed and it is concluded that it has a definite place in The treatment of gastric and duodenal ulcer disease.


Journal Identifiers


eISSN: 2078-5135
print ISSN: 0256-9574